INC280

· Novartis

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for INC280, covering 2017-01-09 to 2024-03-05. Get the full timeline:

Most recent: Clinical Trial Update: LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma [Phase 2]

See pricing